Aug 5, 2026 04:05PM
Jun 3, 2026 07:02AM
Jun 3, 2026 07:00AM
Jun 2, 2026 04:30PM
Jun 2, 2026 04:30PM
May 15, 2026 06:01AM
May 15, 2026 06:01AM Positive Interim Data from Cohorts 1 and 2 of Tenaya’s RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Demonstrated Consistent Reductions in Arrhythmia Burden for Adults with PKP2-associated ARVC
May 6, 2026 04:05PM
Apr 27, 2026 08:30AM
Apr 27, 2026 08:30AM
Mar 11, 2026 04:05PM
Jan 9, 2026 08:30AM
Dec 18, 2025 06:33AM
Dec 11, 2025 04:01PM Tenaya Therapeutics reports positive interim data from gene therapy trial
Dec 11, 2025 04:01PM
Dec 11, 2025 04:01PM
Dec 11, 2025 04:01PM
Nov 10, 2025 07:00AM
Nov 8, 2025 11:25AM
Nov 8, 2025 11:25AM
Aug 31, 2025 10:15AM Tenaya Therapeutics Presents Interim Data from MyClimb™ Natural History Study of MYBPC3-associated HCM Pediatric Patients at European Society of Cardiology Congress 2025
Jul 30, 2025 08:32AM
Jul 30, 2025 08:30AM
Apr 24, 2025 02:08PM
Apr 24, 2025 02:07PM
Mar 31, 2025 10:00AM
Feb 3, 2025 08:30AM
Feb 3, 2025 08:30AM Tenaya Therapeutics Receives $8 Million Clinical Grant from California Institute for Regenerative Medicine
Jan 13, 2025 09:17AM
Jan 13, 2025 09:16AM
Dec 17, 2024 07:01AM
Dec 17, 2024 07:00AM
Nov 25, 2024 08:30AM
Nov 6, 2024 04:05PM
Oct 17, 2024 04:31PM Tenaya Therapeutics (TNYA) Announces Updates on TN-201 Gene Therapy Program
Oct 17, 2024 04:30PM
Aug 8, 2024 04:05PM
Mar 18, 2024 04:05PM
Mar 18, 2024 08:30AM
Feb 26, 2024 08:32AM
Feb 26, 2024 08:30AM
Nov 8, 2023 04:05PM Tenaya Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
Oct 26, 2023 08:31AM
Oct 26, 2023 08:30AM
Oct 5, 2023 08:30AM
Aug 9, 2023 04:05PM
May 10, 2023 04:19PM
May 2, 2023 07:50AM
May 2, 2023 07:50AM Tenaya Therapeutics Receives FDA Fast Track Designation for TN-201
Mar 8, 2023 04:01PM

328,094 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All